| 000 | 01772 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516060153.0 | ||
| 264 | 0 | _c20140203 | |
| 008 | 201402s 0 0 eng d | ||
| 022 | _a1437-7772 | ||
| 024 | 7 |
_a10.1007/s10147-011-0326-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMizowaki, Takashi | |
| 245 | 0 | 0 |
_aLong-term outcomes of three-dimensional conformal radiation therapy combined with neoadjuvant hormonal therapy for Japanese patients with T1c-T2N0M0 prostate cancer. _h[electronic resource] |
| 260 |
_bInternational journal of clinical oncology _cDec 2012 |
||
| 300 |
_a562-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAsian People |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 |
_aProstate-Specific Antigen _xmetabolism |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aRadiotherapy Dosage |
| 650 | 0 | 4 | _aRadiotherapy, Conformal |
| 650 | 0 | 4 |
_aRadiotherapy, Intensity-Modulated _xmethods |
| 650 | 0 | 4 | _aSalvage Therapy |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aTakayama, Kenji | |
| 700 | 1 | _aNorihisa, Yoshiki | |
| 700 | 1 | _aOgura, Masakazu | |
| 700 | 1 | _aKamba, Tomomi | |
| 700 | 1 | _aInoue, Takahiro | |
| 700 | 1 | _aShimizu, Yosuke | |
| 700 | 1 | _aKamoto, Toshiyuki | |
| 700 | 1 | _aOgawa, Osamu | |
| 700 | 1 | _aHiraoka, Masahiro | |
| 773 | 0 |
_tInternational journal of clinical oncology _gvol. 17 _gno. 6 _gp. 562-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10147-011-0326-z _zAvailable from publisher's website |
| 999 |
_c21205111 _d21205111 |
||